Alkermes Plc (ALKS)
Healthcare
Drug Manufacturers - Specialty & Generic
49.50 $
+1.1%
vs. previous close
Closing price · As of: 3. Aug 2026
Alkermes Plc (ALKS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 496 million $. Tick rows to compare them in a chart.
| Tick rows to compare them in a chart (up to 4) | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 381 | 377 | 350 | 399 | 378 | 430 | 307 | 391 | 394 | 385 | 393 | 496 | 1,668 | |
| 61 | 70 | 59 | 61 | 63 | 62 | 49 | 49 | 52 | 46 | 62 | 98 | 257 | |
| 319 | 307 | 292 | 338 | 315 | 368 | 257 | 341 | 343 | 338 | 331 | 398 | 1,410 | |
| 65 | 21 | 68 | 60 | 60 | 57 | 72 | 77 | 82 | 93 | 103 | 113 | 391 | |
| 42 | 24 | 54 | 48 | 48 | 48 | 49 | 50 | 56 | 101 | 109 | 63 | 329 | |
| 230 | 129 | 248 | 228 | 210 | 205 | 244 | 248 | 254 | 280 | 380 | 380 | 1,293 | |
| 89 | 179 | 43 | 110 | 105 | 163 | 14 | 93 | 89 | 58 | -48 | 18 | 117 | |
| 6.0 | 6.1 | 6.0 | 6.0 | 6.0 | 4.6 | 0.0 | 0.0 | 0.0 | 12 | 21 | 26 | 59 | |
| 93 | 182 | 47 | 117 | 110 | 170 | 25 | 105 | 101 | 60 | -62 | -1.9 | 97 | |
| 1.2 | -94 | 8.0 | 22 | 17 | 24 | 3.0 | 18 | 18 | 11 | 4.6 | -2.4 | 31 | |
| 48 | 113 | 37 | 91 | 92 | 147 | 22 | 87 | 83 | 49 | -66 | 0.5 | 66 | |
| 117 | 207 | 61 | 129 | 123 | 181 | 33 | 113 | 109 | 77 | -22 | 54 | 218 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.